Biolife Solutions (BLFS) Gross Profit (2010 - 2026)

Biolife Solutions (BLFS) has reported Gross Profit for 17 consecutive years, with $18.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 20.03% year-over-year to $18.3 million in Q2 2026; TTM through Jun 2026 was $63.7 million, a 20.02% increase from a year earlier, with the FY2025 full-year figure at $62.1 million, up 24.0% from the prior year.
• Gross Profit was $18.3 million for Q2 2026 at Biolife Solutions, up from $17.5 million in the prior quarter.
• Over five years, Gross Profit peaked at $19.3 million in Q1 2023 and troughed at -$11.5 million in Q4 2023.
• A 5-year average of $13.1 million and a median of $15.5 million in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit sank 301.23% in 2023 and soared 168.57% in 2024, its largest moves.
• Over 5 years, Gross Profit stood at -$2.9 million in 2022, then slumped by 301.23% to -$11.5 million in 2023, then soared by 168.57% to $7.9 million in 2024, then gained by 16.15% to $9.1 million in 2025, then surged by 100.52% to $18.3 million in 2026.
• The last three Gross Profit figures came in at $18.3 million (Q2 2026), $17.5 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.